Investors sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading on Monday. $268.75 million flowed into the stock on the tick-up and $349.28 million flowed out of the stock on the tick-down, for a money net flow of $80.53 million out of the stock. Of all equities tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $4.73 for the day and closed at $225.69

UNH has been the topic of several recent research reports. Oppenheimer lifted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and set a $208.00 target price on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Leerink Swann reiterated a “buy” rating and set a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Finally, Argus lifted their target price on shares of UnitedHealth Group from $215.00 to $230.00 and gave the stock a “buy” rating in a research report on Thursday, October 19th. Two investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $243.22.

The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The stock has a market cap of $219,630.00, a price-to-earnings ratio of 23.94, a PEG ratio of 1.32 and a beta of 0.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same quarter last year, the business earned $2.11 EPS. The company’s revenue was up 9.5% compared to the same quarter last year. equities research analysts anticipate that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.32%. UnitedHealth Group’s payout ratio is 31.58%.

In other news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michele J. Hooper sold 10,000 shares of UnitedHealth Group stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the sale, the director now owns 37,284 shares of the company’s stock, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 53,396 shares of company stock valued at $12,262,067. Company insiders own 0.89% of the company’s stock.

Several large investors have recently added to or reduced their stakes in UNH. Exane Derivatives increased its stake in UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares in the last quarter. Aevitas Wealth Management Inc. bought a new stake in UnitedHealth Group during the 4th quarter valued at $102,000. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group during the 2nd quarter valued at $110,000. Bruderman Asset Management LLC bought a new stake in UnitedHealth Group during the 2nd quarter valued at $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares in the last quarter. Institutional investors own 86.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Investors Sell UnitedHealth Group (UNH) on Strength (UNH)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2018/02/14/investors-sell-unitedhealth-group-unh-on-strength-unh-2.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.